|1.||Harvey, Robert J: 8 articles (12/2013 - 01/2008)|
|2.||Topf, Maya: 5 articles (12/2013 - 09/2008)|
|3.||Rees, Mark I: 5 articles (08/2012 - 01/2008)|
|4.||James, Victoria M: 4 articles (12/2013 - 04/2012)|
|5.||Harvey, Kirsten: 4 articles (08/2012 - 01/2008)|
|6.||Chung, Seo-Kyung: 4 articles (08/2012 - 01/2008)|
|7.||Thomas, Rhys H: 3 articles (08/2012 - 01/2010)|
|8.||Pearce, Brian R: 3 articles (08/2012 - 01/2008)|
|9.||Carta, Eloisa: 3 articles (08/2012 - 01/2008)|
|10.||Gill, Jennifer L: 2 articles (08/2012 - 04/2012)|
08/17/2012 - "Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, producing hypertonia and apnea episodes. "
08/17/2012 - "Hereditary hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, leading to hypertonia and apnea episodes. "
09/01/2006 - "Neonatal startle disease with severe apnea episodes: report of one case."
12/01/2013 - "Startle disease is an inherited neurological disorder that causes affected individuals to suffer noise- or touch-induced non-epileptic seizures, excessive muscle stiffness and neonatal apnea episodes. "
09/01/2006 - "Herein, we report one case with hereditary startle disease accompanied with cyanosis and severe apneas, which could be relieved by forced knee-chest position and oral clonazepam. "
01/01/2011 - "The identification of these sites may help to understand the physiological role of this modulation and facilitate the development of novel therapeutic approaches to diseases such as spasticity, startle disease and possibly chronic pain."
11/01/2013 - "The two major subtypes of glycine transporters, GlyT1 and GlyT2, have been linked to the pathogenesis and/or treatment of central and peripheral nervous system disorders, including schizophrenia and related affective and cognitive disturbances, alcohol dependence, pain, epilepsy, breathing disorders and startle disease (also known as hyperekplexia). "
|4.||Nervous System Diseases (Neurological Disorders)
01/01/2010 - "Human startle disease, also known as hyperekplexia (OMIM 149400), is a paroxysmal neurological disorder caused by defects in glycinergic neurotransmission. "
10/01/2004 - "Heritable mutations to human GlyR genes give rise to a rare neurological disorder, hyperekplexia (or startle disease). "
03/03/2004 - "Human hereditary hyperekplexia ("startle disease") is a neurological disorder characterized by exaggerated, convulsive movements in response to unexpected stimuli. "
10/01/1999 - "Hyperekplexia (MIM 149400), or startle disease, is a neurological disorder characterized by generalized stiffness during the neonatal period, excessive startle reflexes, and generalized stiffness related to the startle response. "
08/01/1997 - "Hyperekplexia (MIM: 149400), or startle disease, is an autosomal dominant neurological disorder characterized by an extreme generalized stiffness immediately after birth, normalizing during the first years of life. "
04/01/2012 - "Startle disease affects newborn children and involves an exaggerated startle response and muscle hypertonia in response to acoustic or tactile stimuli. "
02/01/2012 - "Hyperekplexia is characterized by neonatal hypertonia and exaggerated startle reflex in response to loud noise or tactile stimuli. "
01/01/2010 - "Hyperekplexia is characterised by an exaggerated startle reflex in response to tactile or acoustic stimuli which first presents as neonatal hypertonia, followed in some with episodes of life-threatening infantile apnoea. "
09/01/2008 - "Hyperekplexia is characterised by neonatal hypertonia and an exaggerated startle reflex in response to acoustic or tactile stimuli. "
01/01/2008 - "Defects in mammalian glycinergic neurotransmission result in a complex motor disorder characterized by neonatal hypertonia and an exaggerated startle reflex, known as hyperekplexia (OMIM 149400). "
|2.||Glycine Receptors (Glycine Receptor)
|3.||Jumping Frenchmen of Maine
|5.||Glycine (Aminoacetic Acid)
|8.||glycine receptor alpha1